SCHEMBL174930

SCHEMBL174930

Cc1ccc(NC(=O)Nc2cccc3c2CCN3)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.52
STING1 Q86WV6 1/20 0.49
KDR P35968 3/20 0.48
NPC1 O15118 6/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
MAPT P10636 3/20 0.44
TP53 P04637 2/20 0.44
POLB P06746 1/20 0.44
GBA1 P04062 1/20 0.44
KDM4E B2RXH2 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
P2RY1 P47900 2/20 0.42
P2RY2 P41231 1/20 0.42
P2RY14 Q15391 1/20 0.42
MEN1 O00255 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4569778 0.88 MEN1 (0.53) RAB9AKDRNPC1SMN1; SMN2MAPT
SCHEMBL174986 0.87 KMT2A (0.52) RAB9AKDRNPC1SMN1; SMN2MAPT
SCHEMBL174936 0.87 MEN1 (0.51) RAB9ASTING1NPC1SMN1; SMN2MAPT
SCHEMBL175262 0.86 SMN1; SMN2 (0.55) RAB9ANPC1SMN1; SMN2MAPTTP53
Hydrochloric Acid SCHEMBL174066 0.86 KMT2A (0.51) RAB9AKDRNPC1SMN1; SMN2MAPT
SCHEMBL175067 0.85 MAPT (0.52) RAB9AKDRSMN1; SMN2MAPTPOLB
SCHEMBL174238 0.84 DDX3X (0.52) RAB9AKDRNPC1MAPTTP53
SCHEMBL175419 0.84 MAPT (0.54) RAB9ASTING1KDRMAPTP2RY1
SCHEMBL173846 0.80 STING1 (0.53) RAB9ASTING1KDRNPC1MAPT
SCHEMBL175118 0.79 RAB9A (0.58) RAB9AKDRNPC1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP claimed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO claimed
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP disclosed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO disclosed